Navigation Links
Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
Date:12/6/2012

SOUTHPORT, Conn., Dec. 6, 2012 /PRNewswire/ --  A three-member panel of the American Abritration Association today awarded former executives of Applied Biosystems, Inc., f/k/a Perkin Elmer Corporation, $17.4 million in unpaid change in control benefits from Life Technologies Corporation, one of the world's largest biotechnology companies. (NASDAQ:   LIFE).  The case was presented to a former federal judge, former state judge and a senior member of the Connecticut Bar over a period of two years.  According to the claim of the executives, the incentive compensation became due from Life Technologies Corporation when it assumed the obligations of the executives' employment agreements after acquiring Applied Biosystems, Inc. in November 2008.  Life Technologies argued the executives were misreading their agreements and were not entitled to continued stock-based benefit awards.   

In finding for the executives, the arbitration Panel held the agreements were breached as "the Company made no effort to provide [the claimed benefits], and the Claimants are entitled to them."  "We are very pleased with the outcome, and are happy our clients will finally receive these sums which they earned and are long overdue," said Scott Lucas, lead trial counsel for the executives.  "Consultants from Citrin Cooperman were instrumental in helping us present our clients' complex damages claim to the Panel," added Jeff Bagnell, who handled the damages aspect of the case at trial. 

The executives were represented by Lucas Bagnell Varga LLC in Southport, Connecticut.  Life Technologies was represented by DLA Piper.

Media Contact:
Jeff Bagnell
1-203-227-8400
jbagnell@lbv-law.com


'/>"/>
SOURCE Lucas Bagnell Varga LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
2. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
3. Roka Bioscience Secures $47.5 Million in Series D Financing
4. Generex Secures Commitments for $3.6M Capital Raise
5. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
6. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
7. Bacterin Secures $25 Million Financing with OrbiMed
8. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
9. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
10. Syngenta Secures EU Approval For Next Generation Fungicide
11. Amarantus BioSciences Secures $1.1 Million in Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):